Catalyst Event

Eli Lilly and Co (LLY) · Other

From Akros SCHK HK-Global Quality Factor Index (ASHGQLT)

5/13/2026, 12:00:00 AM

OtherSentiment: Positive

Analysts estimate that the launch of the Alzheimer's drug donanemab in India on May 13, 2026, will have a low price impact of ≥1% and is scheduled.

Korean Translation

분석가들은 2026년 5월 13일로 예정된 인도 내 알츠하이머 치료제 도나네맙 출시가 1% 이상의 낮은 주가 영향력을 미칠 것으로 예상됨.

Related Recent Events

View Full Timeline